首页> 美国卫生研究院文献>Cell Death Disease >SP1-induced lncRNA-ZFAS1 contributes to colorectal cancer progression via the miR-150-5p/VEGFA axis
【2h】

SP1-induced lncRNA-ZFAS1 contributes to colorectal cancer progression via the miR-150-5p/VEGFA axis

机译:SP1诱导的lncRNA-ZFAS1通过miR-150-5p / VEGFA轴促进结直肠癌的进展

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Increasing long non-coding RNAs (lncRNAs) have been reported to play key roles in the development and progression of various malignancies. ZNFX1 antisense RNA1 (ZFAS1) has been reported to be aberrant expression and suggested as a tumor suppressor or oncogene in many cancers. However, the biological role and underlying molecular mechanism of ZFAS1, especially the miRNA sponge role of which in CRC remain largely unknown. We found that ZFAS1 expression was higher in CRC tissues, where it was associated with poor overall survival (OS), we also showed that ZFAS1 upregulation was induced by nuclear transcription factor SP1. Moreover, ZFAS1 and VEGFA are both targets of miR-150-5p, while ZFAS1 binds to miR-150-5p in an AGO2-dependent manner. Additionally, ZFAS1 upregulation markedly promoted as well as ZFAS1 knockdown significantly suppressed CRC cell proliferation, migration, invasion and angiogenesis, and the inhibitory effect caused by ZFAS1 knockdown could be reversed by antagomiR-150-5p. Lastly, we demonstrated that ZFAS1 knockdown inhibited EMT process and inactivated VEGFA/VEGFR2 and downstream Akt/mTOR signaling pathway in CRC. Our data demonstrated that SP1-induced ZFAS1 contributed to CRC progression by upregulating VEGFA via competitively binding to miR-150-5p, which acts as a tumor suppressor by targeting VEGFA in CRC.
机译:据报道,越来越长的非编码RNA(lncRNA)在各种恶性肿瘤的发生和发展中起着关键作用。 ZNFX1反义RNA1(ZFAS1)已被报道异常表达,并被建议作为许多癌症中的肿瘤抑制因子或癌基因。然而,ZFAS1的生物学作用和潜在的分子机制,尤其是其在CRC中的miRNA海绵作用仍然未知。我们发现ZFAS1在CRC组织中的表达较高,这与整体生存率(OS)差有关,我们还显示ZFAS1的上调是由核转录因子SP1诱导的。此外,ZFAS1和VEGFA都是miR-150-5p的靶标,而ZFAS1以AGO2依赖性方式与miR-150-5p结合。此外,显着促进ZFAS1的上调以及ZFAS1的敲低显着抑制了CRC细胞的增殖,迁移,侵袭和血管生成,而antagomiR-150-5p可以逆转ZFAS1敲低引起的抑制作用。最后,我们证明ZFAS1敲低抑制CRC中的EMT过程并灭活VEGFA / VEGFR2和下游Akt / mTOR信号通路。我们的数据表明,SP1诱导的ZFAS1通过与miR-150-5p竞争性结合来上调VEGFA,从而促进CRC的进展,而miR-150-5p通过靶向CRC中的VEGFA而起着抑癌作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号